AMMAN —
Nizar Mhaidat, the general-director of
the
Jordan Food and Drug Administration, announced on Saturday the details of
the third international conference on medicine titled "Royal Directives to
Achieving Pharmaceutical Security".
اضافة اعلان
The conference, which will take place in
Amman, aims to facilitate the exchange of ideas, initiatives, and strategies
aligned with the
Royal vision to enhance pharmaceutical security.
The goal is to develop a comprehensive plan
that empowers the sector, fosters its growth, and eliminates barriers for
expanding exports to global markets.
Diverse participation reflecting Arab health
authorities
Mhaidat revealed that this significant
scientific event will witness the participation of esteemed speakers from
various Arab health authorities, including Saudi Arabia, Iraq, Algeria,
Palestine, Lebanon, and Egypt.
Additionally, over 35 speakers and 30
presenters from Arab and foreign countries such as Lebanon, Canada, France,
Britain, Brazil, Belgium, and Germany will contribute to the conference.
Attendees will represent
pharmaceutical authorities, warehouses, local and foreign drug companies, health institutions,
academia, the
World Health Organization, and international organizations.
Six axes of discussion
The conference will span two days and
encompass six main axes of discussion, as explained by Mhaidat.
The first axis aims to enhance the
investment environment in the pharmaceutical industry. It will explore mechanisms and
strategies aligned with the Royal vision for economic update, with the goal of
creating an attractive investment environment in Jordan and overcoming
associated challenges.
The second axis focuses on the supervisory and
legislative role of authorities in enhancing pharmaceutical security and
ensuring access to safe and effective medications. This axis will cover
important developments in drug control, encompassing registration, inspection,
supply chains, and pharmacovigilance, at the local, regional, and global
levels.
Addressing the importance of
research and development (R&D) in the pharmaceutical industry, the third axis emphasizes
its role in achieving pharmaceutical security and enhancing the national
economy.
Key factors influencing R&D in regional
and
global pharmaceutical industries will be explored, along with initiatives
to promote collaboration between academia and the pharmaceutical sector.
The fourth axis aims to enhance integration
among Arab industries and establish unified procedures. A safe conceptual
framework to achieve Arab and regional pharmaceutical security will be
developed, emphasizing the significance of cooperation and coordination among
Arab regulatory authorities.
The fifth axis will discuss strategies to
empower biotechnology and biopharmaceutical industries, focusing on the role of
regulatory legislation in this process. Additionally, the establishment of a
pharmaceutical research center to support these efforts and enhance human
capacity development will be addressed.
Lastly, the sixth axis will shed light on the
importance of pharmaceutical innovations and value-added drugs in
pharmaceutical security. Access to innovative drugs and value-added medications
for patients will be explored as a crucial aspect of achieving pharmaceutical
security.
Read more National news
Jordan News
.jpg)
.jpg)
